21 results on '"Yao, Li-Chin"'
Search Results
2. A novel tumor-bearing humanized mouse model for evaluating the efficacy and predictive safety of bispecific T cell engager
3. Abstract 5189: Comparisons of Rituximab and CD19xCD3 BiTE antitumor response across multiple humanized NSG strains engrafted with human hematopoietic stem cells
4. Table S1, Table S3, Figures S1-S8 from Characterization of the Selective Indoleamine 2,3-Dioxygenase-1 (IDO1) Catalytic Inhibitor EOS200271/PF-06840003 Supports IDO1 as a Critical Resistance Mechanism to PD-(L)1 Blockade Therapy
5. Data from Characterization of the Selective Indoleamine 2,3-Dioxygenase-1 (IDO1) Catalytic Inhibitor EOS200271/PF-06840003 Supports IDO1 as a Critical Resistance Mechanism to PD-(L)1 Blockade Therapy
6. Supplementary Methods from Characterization of the Selective Indoleamine 2,3-Dioxygenase-1 (IDO1) Catalytic Inhibitor EOS200271/PF-06840003 Supports IDO1 as a Critical Resistance Mechanism to PD-(L)1 Blockade Therapy
7. Table S2 from Characterization of the Selective Indoleamine 2,3-Dioxygenase-1 (IDO1) Catalytic Inhibitor EOS200271/PF-06840003 Supports IDO1 as a Critical Resistance Mechanism to PD-(L)1 Blockade Therapy
8. Data from VEGF and c-Met Blockade Amplify Angiogenesis Inhibition in Pancreatic Islet Cancer
9. Supplementary Methods from VEGF and c-Met Blockade Amplify Angiogenesis Inhibition in Pancreatic Islet Cancer
10. Supplementary Figure Legends 1-2 from VEGF and c-Met Blockade Amplify Angiogenesis Inhibition in Pancreatic Islet Cancer
11. Supplementary Figure 2 from VEGF and c-Met Blockade Amplify Angiogenesis Inhibition in Pancreatic Islet Cancer
12. Supplementary Table 1 from VEGF and c-Met Blockade Amplify Angiogenesis Inhibition in Pancreatic Islet Cancer
13. Supplementary Figure 1 from VEGF and c-Met Blockade Amplify Angiogenesis Inhibition in Pancreatic Islet Cancer
14. 1427 Comparative analysis of human immune subsets and Rituximab antitumor response across multiple NSG strains engrafted with human hematopoietic stem cells
15. 1250 A novel in vivo PBMC humanized mouse platform for long-term analysis of efficacy and toxicity of T cell-based immunotherapy drugs
16. Enhanced development of functional human NK cells in NOD‐scid‐IL2rgnull mice expressing human IL15
17. Abstract 2875: Development of a new tumor-bearing humanized mouse model to evaluate the efficacy and toxicity of bispecific T cell engagers
18. Abstract 1640: Enhanced development of functional human innate immune cells in a novel FLT3nullNSG mouse strain expressing human FLT3L
19. Abstract 1338: Humanized mouse model for in vivo evaluation of bispecific antibody efficacy
20. Enhanced development of functional human NK cells in NOD‐scid‐IL2rgnull mice expressing human IL15.
21. Development of a Novel Solid Tumor-Bearing Humanized Animal Model for Simultaneously Evaluating the Toxicity and Efficacy of Bispecific T Cell Engager
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.